Subscribe
Mohammed_Al_Ali / Shutterstock.com
25 June 2024NewsAmericasLiz Hockley

Eli Lilly takes further action over ‘dangerous’ diabetes drug fakes

US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss. 

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Pharmacy defends Eli Lilly off-label drug suit
11 April 2024   Diabetes drug is known for its off-label use as a weight-loss aid | Judge censures pharma giant for using state law instead of federal law in complaint | Development follows a wave of litigation involving Mounjaro.
Big Pharma
Teva and Eli Lilly end patent clash over migraine drug
28 November 2023   Rival drugmakers have dropped lawsuit following invalidation of Teva patents in September | Move comes after judge overturned jury verdict handing $176.5m to Teva.


Editor's picks

Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024

Editor's picks

Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024
article
Looking back at the UPC’s ‘successful’ first year
4 June 2024
Biotechnology
BioNTech’s patent counsel on fostering groundbreaking innovation
2 May 2024

More on this story

Big Pharma
Pharmacy defends Eli Lilly off-label drug suit
11 April 2024   Diabetes drug is known for its off-label use as a weight-loss aid | Judge censures pharma giant for using state law instead of federal law in complaint | Development follows a wave of litigation involving Mounjaro.
Big Pharma
Teva and Eli Lilly end patent clash over migraine drug
28 November 2023   Rival drugmakers have dropped lawsuit following invalidation of Teva patents in September | Move comes after judge overturned jury verdict handing $176.5m to Teva.

More on this story

Big Pharma
Pharmacy defends Eli Lilly off-label drug suit
11 April 2024   Diabetes drug is known for its off-label use as a weight-loss aid | Judge censures pharma giant for using state law instead of federal law in complaint | Development follows a wave of litigation involving Mounjaro.
Big Pharma
Teva and Eli Lilly end patent clash over migraine drug
28 November 2023   Rival drugmakers have dropped lawsuit following invalidation of Teva patents in September | Move comes after judge overturned jury verdict handing $176.5m to Teva.

More features

Pfizer, Moderna vow appeals after split vaccine ruling
Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice
UK biotech aims at US rival over genome sequencing technology
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
Earthquake Chevron: A massive shock to the system?
Carpmaels & Ransford expands life sciences partnership
Report reveals boom in digital health patents
Dority & Manning life sciences head joins WBD